SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $116 | – | 89 | +7.2% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 83 | -42.0% | 0.00% | – |
| Q3 2022 | $1,000 | -94.1% | 143 | -95.2% | 0.00% | – |
| Q1 2022 | $17,000 | +112.5% | 3,000 | +124.7% | 0.00% | – |
| Q4 2021 | $8,000 | -85.5% | 1,335 | -78.2% | 0.00% | – |
| Q3 2021 | $55,000 | -24.7% | 6,135 | 0.0% | 0.00% | – |
| Q2 2021 | $73,000 | -5.2% | 6,135 | 0.0% | 0.00% | – |
| Q1 2021 | $77,000 | -19.8% | 6,135 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $96,000 | +81.1% | 6,135 | +9.8% | 0.00% | – |
| Q3 2020 | $53,000 | +341.7% | 5,585 | +334.6% | 0.00% | – |
| Q2 2020 | $12,000 | +50.0% | 1,285 | +2.8% | 0.00% | – |
| Q1 2020 | $8,000 | 0.0% | 1,250 | +25.0% | 0.00% | – |
| Q4 2019 | $8,000 | -11.1% | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | -18.2% | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $11,000 | +120.0% | 1,000 | +94.2% | 0.00% | – |
| Q1 2019 | $5,000 | -16.7% | 515 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -33.3% | 515 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | -25.0% | 515 | -41.1% | 0.00% | – |
| Q2 2018 | $12,000 | +33.3% | 875 | +80.4% | 0.00% | – |
| Q1 2018 | $9,000 | -52.6% | 485 | -58.2% | 0.00% | – |
| Q4 2017 | $19,000 | +11.8% | 1,160 | 0.0% | 0.00% | – |
| Q3 2017 | $17,000 | +70.0% | 1,160 | 0.0% | 0.00% | – |
| Q2 2017 | $10,000 | 0.0% | 1,160 | -42.0% | 0.00% | – |
| Q1 2017 | $10,000 | -16.7% | 2,000 | -23.1% | 0.00% | – |
| Q3 2016 | $12,000 | -96.0% | 2,600 | -94.9% | 0.00% | -100.0% |
| Q2 2016 | $297,000 | +130.2% | 51,300 | +140.8% | 0.00% | +100.0% |
| Q1 2016 | $129,000 | -50.0% | 21,300 | -8.6% | 0.00% | -50.0% |
| Q2 2015 | $258,000 | -29.3% | 23,300 | 0.0% | 0.00% | -20.0% |
| Q1 2015 | $365,000 | +9.0% | 23,300 | +5.9% | 0.01% | 0.0% |
| Q4 2014 | $335,000 | +41.4% | 22,000 | 0.0% | 0.01% | +66.7% |
| Q3 2014 | $237,000 | -29.5% | 22,000 | 0.0% | 0.00% | -40.0% |
| Q2 2014 | $336,000 | -15.6% | 22,000 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $398,000 | +30.1% | 22,000 | 0.0% | 0.01% | +50.0% |
| Q4 2013 | $306,000 | +32.5% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $231,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |